Unclaimed Scholar Profile
Are you Judy Wambui Mwangi? This profile has been curated from verified academic registries. Claim your profile to edit affiliations, manage works, and access your dashboard.
Verified ScholarVerified at Mount Kenya UniversityASIDASID-2282-2458-1332 orcid.org/0000-0002-7508-4937
Judy Wambui Mwangi
Mount Kenya University•Kenya
Faculty researcher at Mount Kenya University (Kenya), specializing in Health & Medical Sciences. [Discipline: Health & Medical Sciences] [Country: Kenya] [Region: East Africa]
#HIV/AIDS drug development and treatment#Criminal Justice and Penology#Policing Practices and Perceptions#Hepatitis C virus research
Scholarly Profiles: Google Scholar
Citation Indices
Standard Scientometrics| All | Since 2021 | |
|---|---|---|
| Citations | 634 | 304 |
| h-index | 9 | 7 |
| i10-index | 9 | 6 |
Annual Citation Growth
Verified Citations / Year0
202030
2021+43%43
2022+28%55
2023+33%73
2024-8%67
2025-46%36
2026Scholarship Distribution & Proportions42 Articles • 0 Books & Monographs • 0 Applied Assignments
Continental Provenance:82% African Regional Citations (520) • 18% Global Research Impact (114)
42 Indexed WorksAuthentic Data
Co-Authors & Academic Collaborators
No verified co-authors registered on AfriJournal Index yet.
Browse African Scholars →Scientific Bibliography Ingestion Notice
AfriJournal Index synchronizes authentic African citations and scholarship from Crossref, OpenAlex, and verified institutional repositories. Due to external indexing latency, some historical works may not yet be ingested in this snapshot. If you are this scholar, claim this profile to link your ORCID and verify your complete bibliography.
Articles & Books (42)
Clinical targeting of HIV capsid protein with a long-acting small molecule
Published in Nature•2020
DOI: 10.1038/s41586-020-2443-1 Verified Peer-Reviewed
Preclinical Characterization of GS-9669, a Thumb Site II Inhibitor of the Hepatitis C Virus NS5B Polymerase
Published in Antimicrobial Agents and Chemotherapy•2012
DOI: 10.1128/aac.02052-12 Verified Peer-Reviewed
Discovery of GS-9669, a Thumb Site II Non-Nucleoside Inhibitor of NS5B for the Treatment of Genotype 1 Chronic Hepatitis C Infection
Published in Journal of Medicinal Chemistry•2013
DOI: 10.1021/jm401420j Verified Peer-Reviewed
Long-acting capsid inhibitor protects macaques from repeat SHIV challenges
Published in Nature•2021
DOI: 10.1038/s41586-021-04279-4 Verified Peer-Reviewed
Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis
Published in Journal of Medicinal Chemistry•2025
DOI: 10.1021/acs.jmedchem.5c01625 Verified Peer-Reviewed
Showing 1 – 5 of 42 publications
1 / 9